Thalidomide-benzo is primarily utilized in the field of medicinal chemistry and pharmaceutical research due to its potential therapeutic properties. It is often studied for its anti-inflammatory, immunomodulatory, and anti-angiogenic effects, which make it a candidate for treating conditions such as certain cancers, autoimmune diseases, and inflammatory disorders. Researchers explore its ability to inhibit the production of tumor necrosis factor-alpha (TNF-α), a key cytokine involved in inflammation. Additionally, its structural modifications, like the benzo group, are investigated to enhance its efficacy, reduce side effects, and improve pharmacokinetic properties. This compound is also of interest in the development of targeted therapies, particularly in diseases where angiogenesis plays a critical role, such as multiple myeloma and other solid tumors.